Skip to main content

Eventide Gilead Fund

ETGLX

49.2%

Excluded by weight

33

Excluded companies

55

Total holdings

Holdings as of end-of-period filing dated December 30, 2025. Source: SEC N-PORT filing / fund provider disclosure.

Filter by harm category

Screened out

33 companies · 49.2% by weight
GH4.93%

Guardant Health Inc

See why excluded →
MIRM3.60%

Mirum Pharmaceuticals Inc.

See why excluded →
URI2.59%

United Rentals, Inc.

See why excluded →
GEV2.52%

GE Vernova Inc.

See why excluded →
VRNA2.43%

Verona Pharma Plc

See why excluded →
VST2.24%

Vistra Corp

See why excluded →
INSM2.09%

Insmed Inc

See why excluded →
CHWY1.93%

Chewy Inc

See why excluded →
ARGX1.91%

Argenx SE

See why excluded →
ODFL1.89%

Old Dominion Freight Line Inc.

See why excluded →
SRRK1.87%

Scholar Rock Holding Corp.

See why excluded →
TMDX1.77%

TransMedics Group Inc.

See why excluded →
VMC1.76%

Vulcan Materials Company

See why excluded →
ORLY1.67%

O'Reilly Automotive Inc.

See why excluded →
COLL1.61%

Collegium Pharmaceutical Inc.

See why excluded →
AXSM1.48%

Axsome Therapeutics Inc.

See why excluded →
TRGP1.23%

Targa Resources Corp.

See why excluded →
DHI1.23%

D.R. Horton, Inc.

See why excluded →
LNG1.22%

Cheniere Energy Inc

See why excluded →
FAST1.16%

Fastenal Co.

See why excluded →
LOW1.05%

Lowes Companies, Inc.

See why excluded →
LAD0.94%

Lithia Motors Incorporated

See why excluded →
ISRG0.88%

Intuitive Surgical Inc.

See why excluded →
PANW0.85%

Palo Alto Networks Inc

See why excluded →
VITL0.72%

Vital Farms Inc.

See why excluded →
NVDA0.71%

NVIDIA Corp.

See why excluded →
ROK0.59%

Rockwell Automation, Inc.

See why excluded →
VRSK0.55%

Verisk Analytics, Inc.

See why excluded →
PCVX0.47%

Vaxcyte Inc

See why excluded →
CLDX0.44%

Celldex Therapeutics Inc.

See why excluded →
TTD0.39%

The Trade Desk Inc

See why excluded →
CRWD0.33%

Crowdstrike Holdings Inc

See why excluded →
BBNX0.12%

Beta Bionics Inc.

See why excluded →

Own ETGLX? See your full picture.

This fund is one piece. Scan your entire portfolio to see your total exposure across all holdings and funds.

About this screening

Eventide Gilead Fund applies its own values-based screening methodology. We analyze it because that shared practice — using an ethical framework to exclude companies for non-financial reasons — makes the comparison meaningful. This fund's methodology differs from ours. The purpose of this page is to make those differences tangible and help investors know what they own.